Related Experiment Videos
Gastrointestinal disease in the immunocompromised patient
1College of Physicians and Surgeons of Columbia University, New York, NY.
Human Pathology
|November 1, 1994
Summary
Gastrointestinal (GI) diseases are common in immunocompromised patients, especially those with acquired immunodeficiency syndrome (AIDS). This review details HIV-related GI conditions, comparing them to other immunocompromised patient groups.
Area of Science:
- Gastroenterology
- Immunology
- Infectious Diseases
Background:
- Gastrointestinal (GI) diseases are prevalent in immunocompromised individuals, with the highest incidence observed in patients with acquired immunodeficiency syndrome (AIDS).
- Understanding GI manifestations in immunocompromised states is crucial for diagnosis and management.
Purpose of the Study:
- To review and categorize gastrointestinal diseases in immunocompromised patients, with a focus on human immunodeficiency virus (HIV)-related conditions.
- To compare GI diseases in patients with AIDS to those in other immunocompromised populations.
- To discuss conditions unique to transplant recipients, including graft-versus-host disease (GVHD) and posttransplant lymphoproliferative disorders (PTLDs).
Main Methods:
- Categorization of GI diseases into four main groups: HIV-related inflammatory conditions, non-HIV/opportunistic infection-related inflammatory conditions, opportunistic infections, and neoplasms.
- Discussion of prevalence, pathogenesis, clinical manifestations, gross pathology, and microscopic features for each disease entity.
- Comparative analysis of GI diseases across different immunocompromised patient groups.
Main Results:
- Detailed description of HIV-related enteropathy, proctocolitis, and CD8 lymphocytosis.
- Overview of neutropenic enterocolitis, regional enteritis-like enteropathy, and GVHD.
- Comprehensive listing and discussion of opportunistic infections (viral, fungal, bacterial, parasitic) and neoplasms (Kaposi's sarcoma, lymphomas) affecting the GI tract in immunocompromised patients.
Conclusions:
- Gastrointestinal diseases present a significant challenge in immunocompromised patients, particularly those with HIV/AIDS.
- A systematic approach to classifying these diseases aids in understanding their diverse etiologies and clinical presentations.
- Further research and clinical vigilance are necessary for effective management of GI complications in this vulnerable population.